CPT® Code 0794T

Patient-specific, assistive, rules-based algorithm for ranking pharmaco-oncologic treatment options based on the patient's tumor-specific cancer marker information obtained from prior molecular pathology, immunohistochemical, or other pathology results which have been previously interpreted and reported separately

The CPT® Code 0794T refers to a patient-specific, assistive, rules-based algorithm designed to rank pharmaco-oncologic treatment options tailored to the individual patient's tumor-specific cancer marker information. This information is derived from prior molecular pathology, immunohistochemical, or other pathology results that have been previously interpreted and reported separately. The algorithm is instrumental in providing a systematic approach to evaluating available treatment options, ensuring that the ranking is based solely on FDA-approved drugs. The process begins with the physician or qualified healthcare professional compiling all relevant clinical data specific to the patient's tumor, which includes previously interpreted results from molecular, laboratory, and pathology tests. Importantly, any raw data from genomic sequencing is excluded from this analysis. The output of the algorithm is a comprehensive report that ranks potential therapies, enabling the physician to make informed decisions regarding subsequent treatment plans aimed at effectively targeting the patient's specific cancer.